A comparison of the impact of oral capsule hypericum perforatum and matricaria camomil on hot flashes and sleep disorder in perimenopausal wome
- Conditions
- Hot flashes and sleep disorder in perimenopausal women.Menopausal and female climacteric states
- Registration Number
- IRCT201307302751N9
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 123
Age 45 to 60 years; Having menopausal symptoms for at least 3 months ;Complaining of hot flashes, at least 3 times a day ;Complaining of sleep disturbance for at least 3 months;Total sleep time less than 6 hours ;Not receiving hormone therapy within the last 3 months ;Not receiving treatment for menopause symptoms; Not receiving phytoestrogens such as Soya ;No Heart disease, hypertension, diabetes, epilepsy, any mental illness, thyroid disorders, liver disease, cancer, abnormal uterine bleeding (AUB) ;Not sensitive to any herb; Non-Smoking. Exclusion Criteria :Taking benzodiazepines, hypnotics, anti-coagulants such as aspirin, heparin and warfarin; Not receiving non-hormonal drugs to relieve menopausal symptoms such as clonidine and hormone therapy during the study; Sensitivity to medications used during the study; Not having any systemic disease; Not having tendency to continue the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hot flushing. Timepoint: Baseline, 4 weeks and 8 weeks after. Method of measurement: Daily hot flash form.;Sleep disorder. Timepoint: Baseline, 4 weeks and 8 weeks after. Method of measurement: Pittsburgh Sleep Questionnaire Index.
- Secondary Outcome Measures
Name Time Method o. Timepoint: No. Method of measurement: No.